By | November 24, 2010

FDA Pulls Darvon, Darvocet from Market for Heart Risks

The maker of the pain killer medicine known as Darvon and Darvocet, or propoxyphene, announced last week it will stop making the popular drugs because it can cause serious heart rhythm abnormalities,… Read More

By | November 1, 2010

Doctors on Pharma Payroll Not Always Experts, New Investigation Finds

Do you promise to tell the truth, the whole truth and nothing but the truth, so help you God? It’s a simple, but significant act on which our entire judicial system rests.… Read More

By | September 1, 2010

New Study Warns Meridia Weight Loss Pill Increases Heart Attack, Stroke Risk

People with heart disease who want to lose weight should avoid taking Abbott’s weight loss pill Meridia, according to a new study funded by the drug’s manufacturer. In Europe, the drug, known… Read More

By | July 18, 2010

Avandia Stays on Market Despite Heart Attack Dangers

In a puzzling turn of events this week, an F.D.A. panel voted 20-12 to leave Avandia, from GlaxoSmithKline, on the market but with restrictions because of heart attack risks. Avandia was once the… Read More

By | June 4, 2010

Antacid drugs linked to increased risk of bone fractures, FDA warns

Take a pill for heartburn and you could fracture a bone. While it won’t happen overnight, the FDA released a warning last week informing consumers that long-term use of such drugs, known as proton… Read More

Topics

PAST ARTICLES